FDA Brings Awareness to Driving and OTC Drug Dangers



The Food and Drug Administration (FDA) made it known last week that motor vehicles and certain medications don’t mix. As reported by Kathryn Roethel in the San Francisco Gate, some of those medications are over-the-counter drugs “that are probably in your medicine cabinet.”


Antidiarrheals, motion sickness medications, and antihistamines are non-prescription meds the FDA called out last week in an online briefing about the dangers of driving while using common drugs. Dr. Ali Mohamadi, a medical officer at the FDA’s Center for Drug Evaluation and Research, explained that because these medications are available over the counter, many people discount their risks.

“The drugs’ side effects include drowsiness, slow reflexes and faulty perception of time and distance. Mohamadi recommends patients pay extra attention to instructions and warnings on these products’ Drug Facts labels,” writes Roethel. “Earlier this year the FDA took other steps to decrease medication-related drowsy driving. The agency required makers of two popular prescription sleep aids, Lunesta and Ambien, to cut their starting doses in half, decreasing the amount of drug still in patients’ blood during the next morning’s commute.”


Roethel points out that the National Highway Traffic Safety Administration estimates about 2.5% of fatal car accidents, and 2% of injury crashes involved drowsy drivers. That’s up to 6,000 fatal collisions each year. For the FDA’s online presentation about OTC medications and impaired driving, go to http://1.usa.gov/1qU74eu

The post FDA Brings Awareness to Driving and OTC Drug Dangers appeared first on Sleep Diagnosis and Therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *